HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Z Dong Selected Research

Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)

7/2006Inducible nitric oxide synthase activity is essential for inhibition of prostatic tumor growth by interferon-beta gene therapy.
7/2001Adenovirus-mediated interferon-beta gene therapy suppresses growth and metastasis of human prostate cancer in nude mice.
1/2000Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Z Dong Research Topics

Disease

50Neoplasms (Cancer)
01/2020 - 01/2000
13Carcinogenesis
01/2016 - 01/2000
9Neoplasm Metastasis (Metastasis)
01/2019 - 01/2000
8Nasal Polyps (Nasal Polyp)
10/2001 - 08/2000
7Breast Neoplasms (Breast Cancer)
10/2015 - 08/2001
6Prostatic Neoplasms (Prostate Cancer)
05/2023 - 03/2001
5Body Weight (Weight, Body)
01/2023 - 07/2015
5Infections
01/2019 - 06/2000
5Inflammation (Inflammations)
01/2013 - 03/2001
4Obesity
01/2024 - 07/2015
4Adenocarcinoma
08/2012 - 02/2000
4Necrosis
07/2007 - 03/2000
4Hypoxia (Hypoxemia)
11/2001 - 05/2000
3Periodontitis
01/2024 - 02/2010
3Hypertension (High Blood Pressure)
09/2023 - 02/2022
3Dyslipidemias (Dyslipidemia)
06/2023 - 08/2020
3Snoring
08/2020 - 08/2000
3Carcinoma (Carcinomatosis)
02/2017 - 03/2001
3Skin Neoplasms (Skin Cancer)
03/2016 - 11/2000
3Stomach Neoplasms (Stomach Cancer)
04/2014 - 09/2000
3Colonic Neoplasms (Colon Cancer)
01/2014 - 01/2000
3Ovarian Neoplasms (Ovarian Cancer)
08/2013 - 02/2008
2Insulin Resistance
01/2024 - 06/2012
2Hepatocellular Carcinoma (Hepatoma)
05/2022 - 10/2008
2Chronic Disease (Chronic Diseases)
03/2022 - 08/2020
2Overweight
08/2020 - 06/2012
2Squamous Cell Carcinoma of Head and Neck
01/2019 - 10/2008
2Ischemic Stroke
01/2018 - 05/2015
2Hypersensitivity (Allergy)
01/2018 - 05/2001
2Colorectal Neoplasms (Colorectal Cancer)
10/2017 - 01/2000
2Headache (Headaches)
02/2017 - 09/2013
2Nasopharyngeal Carcinoma
09/2014 - 12/2011
2Pancreatic Neoplasms (Pancreatic Cancer)
10/2009 - 01/2000
2Hepatitis
04/2006 - 06/2000
2Rhinitis
05/2001 - 02/2000
2Obstructive Sleep Apnea
03/2001 - 10/2000

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
09/2023 - 01/2000
10Transcription Factor AP-1 (Transcription Factor AP 1)IBA
11/2004 - 01/2000
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2015 - 02/2000
6TeaIBA
12/2001 - 01/2000
5DNA (Deoxyribonucleic Acid)IBA
02/2016 - 03/2001
4Messenger RNA (mRNA)IBA
01/2015 - 08/2001
4CarcinogensIBA
01/2013 - 01/2000
4Phosphotransferases (Kinase)IBA
04/2012 - 01/2000
4Cisplatin (Platino)FDA LinkGeneric
12/2011 - 07/2006
4NF-kappa B (NF-kB)IBA
02/2008 - 10/2000
4ParaffinIBA
08/2001 - 04/2000
3LigandsIBA
01/2024 - 02/2009
3LeptinIBA
01/2023 - 04/2014
3Glucose (Dextrose)FDA LinkGeneric
02/2022 - 06/2012
3LipidsIBA
02/2022 - 06/2001
3Tissue Plasminogen Activator (Alteplase)FDA Link
01/2018 - 01/2015
3Therapeutic UsesIBA
01/2014 - 01/2000
3Protein Isoforms (Isoforms)IBA
02/2009 - 08/2001
3CaspasesIBA
10/2008 - 05/2000
3Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
10/2008 - 02/2000
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
07/2006 - 01/2000
3Mitogen-Activated Protein KinasesIBA
12/2001 - 01/2000
3PolyphenolsIBA
12/2001 - 01/2000
3arseniteIBA
09/2001 - 01/2000
2oxidized low density lipoproteinIBA
06/2023 - 08/2020
2Pharmaceutical Sleep AidsIBA
08/2020 - 08/2020
2MicroRNAs (MicroRNA)IBA
01/2020 - 08/2013
2STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
02/2016 - 07/2015
2Fibronectins (Fibronectin)IBA
10/2015 - 03/2011
2IntegrinsIBA
10/2015 - 03/2011
2CateninsIBA
08/2014 - 01/2011
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2014 - 01/2013
2LuciferasesIBA
11/2013 - 05/2006
2Adenosine Triphosphate (ATP)IBA
09/2013 - 06/2001
2Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
08/2013 - 02/2008
2CytokinesIBA
06/2011 - 04/2006
2Transforming Growth Factor beta (TGF-beta)IBA
06/2011 - 02/2009
2Transforming Growth Factor beta1 (TGF beta 1)IBA
02/2009 - 07/2001
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
12/2008 - 08/2001
2Caspase 9IBA
10/2008 - 11/2001
2Protein Kinase CIBA
02/2008 - 12/2001
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2007 - 05/2001
2Interferon-betaIBA
07/2006 - 07/2001
2Matrix Metalloproteinases (MMPs)IBA
12/2001 - 08/2001
2Transcription Factors (Transcription Factor)IBA
07/2001 - 06/2001
2Epidermal Growth Factor (EGF)IBA
06/2001 - 01/2000
2CollagenIBA
03/2001 - 10/2000
2Monoclonal AntibodiesIBA
03/2001 - 09/2000
2ResveratrolIBA
02/2001 - 11/2000
2Interleukin-1beta (Interleukin 1 beta)IBA
10/2000 - 08/2000
2epigallocatechin gallate (epigallocatechin-3-gallate)IBA
10/2000 - 01/2000
2JBT-3002IBA
06/2000 - 01/2000
16-formylindolo(3,2-b)carbazoleIBA
01/2024
1tryptamineIBA
01/2024
1indoleacetic acid (indole acetic acid)IBA
01/2024
1indole-3-carbaldehydeIBA
01/2024
1indoleIBA
01/2024

Therapy/Procedure

11Therapeutics
05/2022 - 01/2000
6Chemoprevention
10/2017 - 07/2000
3Drug Therapy (Chemotherapy)
01/2014 - 09/2000
2Oral Administration
01/2024 - 12/2008
2Ligation
01/2024 - 01/2017
2Thyroidectomy
02/2017 - 01/2017
2Radiotherapy
02/2017 - 09/2014